A phase II study of lenvatinib plus everolimus in advanced extra-pancreatic neuroendocrine tumors (epNETs): Updated results and real-world comparison.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Guglielmo Vetere, Zhouxuan Li, Wei Qiao, Daniel M. Halperin, Venkateswar R. Surabhi, Nir Stanietzky, Mackenzie Phillips, Divya Sakamuri, Kaye F. Wilson, Michael Leung, Makenna Smack, James C. Yao, Arvind Dasari
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410815294